Skip to main content

Abstract

This review is dedicated to relevant diabetes mellitus-related aspects in several European countries that emerged after the breakup of the Soviet Union. After more than two decades of existence, these countries significantly differ according to their economic standing, demographic parameters, as well as presence, speed, and orientation of healthcare reforms (Table 11.1). The former “Soviet republics” that prior to 1991 had similar socioeconomic characteristics and identical healthcare system are now independent Eastern European and Baltic states that belong to different socioeconomic and political communities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Such register was functional in Ukraine for some time (2000–2009), and several studies in the field of T1D [41, 42] as well as T2D [4347] were based on its data. Some investigations, based on the Ukrainian Diabetes Mellitus Register, were published in local journals in Ukrainian [4851]; therefore, here we are giving a more detailed presentation of some of that published data about gender aspects of mortality among diabetes patients.

References

  1. The World Bank Data. Countries and economies. http://data.worldbank.org/country. Retrieved 11 Jan 2015.

  2. Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases—where worlds meet. N Engl J Med. 2010;363(13):1196–8. doi:10.1056/NEJMp1002024.

    Article  CAS  PubMed  Google Scholar 

  3. Beran D. The impact of health systems on diabetes care in low and lower middle income countries. Curr Biabetes Rep. 2015;15(4):1–13.

    Google Scholar 

  4. Wilmoth JR, Lundström H. Extreme longevity in five countries. Eur J Popul/Rev Eur Démogr. 1996;12(1):63–93.

    Article  CAS  Google Scholar 

  5. International Diabetes Federation, Diabetes Atlas. 6th ed. Brussels. 2013. http://www.idf.org/diabetesatlas.

  6. http://apps.who.int/healthinfo/statistics/mortality/whodpms/.

  7. Turcanu G, Domente S, Buga M, Richardson E. Republic of Moldova: health system review. Health Syst Transit. 2012;14(7):1–151.

    PubMed  Google Scholar 

  8. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.

    Article  PubMed  Google Scholar 

  9. Dogadin SA, Mashtakov BP, Taranushenko TE. Prevalence of type 2 diabetes in northern populations of Siberia. Int J Circumpolar Health. 2001;60:205–10.

    CAS  PubMed  Google Scholar 

  10. Шишкинa HC, Cунцoв ЮИ, Бoлoтcкaя ЛЛ, Maкcимoвa BП, Cмиpнoв CB, Дeдoв ИИ. Pacпpocтpaнeннocть caxapнoгo диaбeтa 2 типa (пo дaнным cкpинингa). Caxapный диaбeт. 2005;2:7–8. http://cyberleninka.ru/article/n/rasprostranennost-saharnogo-diabeta-2-tipa-po-dannym-skrininga.

    Google Scholar 

  11. Дoгaдин CA, Кpижaнoвcкaя EB, Bинoгpaдoвa CB. Peзультaты cкpинингa житeлeй Кpacнoяpcкa нa caxapный диaбeт. Caxapный диaбeт № 1, 2004, c. 8–10. http://cyberleninka.ru/article/n/rezultaty-skrininga-zhiteley-krasnoyarska-na-saharnyy-diabet.

  12. Khalangot MD, Kravchenko VI, Pisarenko Yu M, Okhrimenko NV, Lerman NG, KovtunVA. Prevalence of diabetes mellitus, impaired glucose regulation, and their anthropometric risk factors in elderly residents of rural. Ukraine Endocrynologia. 2014;19(2):119–25. http://nbuv.gov.ua/j-pdf/enkrl_2014_19_2_7.pdf.[Article in Ukrainian]. n.d.

  13. Khalangot M, Gurianov V, Okhrimenko N, Luzanchuk I, Kravchenko V. Neck circumference as a risk factor of screen-detected diabetes mellitus: community-based study. Diabetol Metabol Syndr. 2016;8:12.

    Google Scholar 

  14. Martirosyan H, Petrosyan V, Crape B, Melkomian DM, Koshkakaryan M, Sahakyan Y, Truzyan N. Rapid appraisal of diabetes care in Armenia: a qualitative research. Yerevan: Center for Health Services Research and Development, American University of Armenia; 2012.

    Google Scholar 

  15. State Statistical Committee of the Republic of Azerbaijan, Baku 2015. www.stat.gov.az.

  16. Kharchanka A, Roubuts T. Morbidity dynamics of diabetes in children living in the West region of Belarus. Endocr Abstr. 2014;35:P805. doi:10.1530/endoabs.35.P805.

    Google Scholar 

  17. Shepelkevich AP. Int J Endocrinol. 2015;4(68):119–21. (In Russian) www.mif-ua.com/archive/article/40847.

    Google Scholar 

  18. Ocoбeннocти oкaзaния диaбeтoлoгичecкoй пoмoщи в Pecпубликe Бeлapуcь нa coвpeмeннoм этaпe / Шeпeлькeвич A.П. [и дp.]. (2012) Ars. Medica 15(70):6–11. http://natbookcat.org.by/isgbi/marcview.do?id=1067461&position=2.

  19. Balabanova D, McKee M, Koroleva N, Chikovani I, Goguadze K, Kobaladze T, … Robles S. Navigating the health system: diabetes care in Georgia. Health Pol Plan. 2009;24(1):46–54.

    Google Scholar 

  20. Georgia Statistical yearbook_2013_eng www.ncdc.ge.

  21. Ministerul Sănătății al Republicii Moldova Centrul Național de Management în Sănătate. ANUARUL STATISTIC AL SISTEMULUI DE SĂNĂTATE DIN MOLDOVA ANUL 2013. Chișinău, 2014.

    Google Scholar 

  22. Dedov II, Shestakova MV, Vikulova OK. National register of diabetes mellitus in Russian Federation: status on 2014 (Article in Russian) Caxapный диaбeт. 2015;18(3):5–23. http://endojournals.ru/index.php/dia/article/view/7235.

  23. Shiryaeva TYu, Andrianova EA, Suntsov YuI. Type 1 diabetes mellitus in children and adolescents of Russian Federation: key epidemiology trends (article in Russian) Caxapныйдиaбeт. 2013;(3):21–29. http://dx.doi.org/10.14341/2072-0351-813.

  24. Дeдoв ИИ, Шecтaкoвa MB (2013). Peзультaты peaлизaции пoдпpoгpaммы «Caxapный диaбeт» фeдepaльнoй цeлeвoй пpoгpaммы «Пpeдупpeждeниe и бopьбa c coциaльнo знaчимыми зaбoлeвaниями 2007–2012 гoды». Caxapныйдиaбeт, (2S).Cпeцвыпуcк [Federal targeted programme “Prevention and Management of Socially Significant Diseases (2007–2012)”: results of the “Diabetes mellitus” sub-programme] (article in Russian). http://cyberleninka.ru/article/n/rezultaty-realizatsii-podprogrammy-saharnyy-diabet-federalnoy-tselevoy-programmy-preduprezhdenie-i-borba-s-sotsialno-znachimymi#ixzz3r1FgzdzE.

  25. Suntsov YuI. Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus. (article in Russian) Caxapный диaбeт. 2012;(1):6–9.http://cyberleninka.ru/article/n/sovremennye-saharosnizhayuschie-preparaty-ispolzuemye-v-rossii-pri-lechenii-saharnogo-diabeta-2-tipa.

  26. Chernobrov AD, editors. Main indicators of endocrinological care of Ukraine for 2015: review. Kyiv: V.P. Komisarenko Institute of Endocrinology and Metabolism of the Acad Med Sci, Ukraine Ministry of Health. Endocrynologia. 2014;19(1) Supplement 1 (data set in Ukrainian).

    Google Scholar 

  27. Mankovsky B. The prevalence of undiagnosed type 2 diabetes mellitus in Ukraine. Diabetologia. 2007;50 Suppl 1:0376.

    Google Scholar 

  28. The Center for Disease Prevention and Control of Latvia. http://www.spkc.gov.lv/about-SPKC/. Accessed 11 June 2015.

  29. The Central Statistics Bureau of Latvia. http://www.csb.gov.lv/en. Accessed 11 June 2015.

  30. Atun R, Jaffar S, Nishtar S, Knaul FM, Barreto ML, Nyirenda M, et al. Improving responsiveness of health systems to noncommunicable diseases. Lancet. 2013;381(9867):690–7.

    Article  PubMed  Google Scholar 

  31. Khalangot M, Tronko M. Primary care diabetes in Ukraine. Prim Care Diabetes. 2007;1(4):203–5.

    Article  PubMed  Google Scholar 

  32. Telishevska M, Chenet L, McKee M. Towards an understanding of the high death rate among young people with diabetes in Ukraine. Diabet Med. 2001;18(1):3–9.

    Article  Google Scholar 

  33. Shields BM, Peters JL, Cooper C, Lowe J, Knight BA, Powell RJ, Hattersley AT. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open. 2015;5(11):e009088.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Royal College of General Practitioners and NHS Diabetes. Coding, classification and diagnosis of diabetes. Secondary coding, classification and diagnosis of diabetes. 2011. http://www.sdrn.org.uk/sites/sdrn.org.uk/files/nhs%20diagnosis%20classification% 20report.pdf.

  35. Pildava S, Strēle I, Briģis Ģ. The mortality of patients with diabetes mellitus in Latvia 2000–2012. Medicina. 2014;50(2):130–6.

    Article  PubMed  Google Scholar 

  36. Dedov II. Diabetes mellitus – a dangerous treat to the mankind. [Article in Russian]. Vestn Ross Akad Med Nauk. 2012;(1):7–13. http://europepmc.org/abstract/med/22550704.

  37. Khalangot MD. Epedemiologic characteristics of diabetes mellitus type1 and 2 according to data from national population-based patient register. [Manuscript in Ukrainian]. Thesis for the Degree of Doctor of Medical Sciences. V.P. Komisarenko Institute of Endocrinology and Metabolism AMS of Ukraine, Kiev; 2009.

    Google Scholar 

  38. Khalangot M, Tronko M, Kravchenko V, Kovtun V. Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study. Diabetes Res Clin Pract. 2009;86(3):247–53.

    Article  CAS  PubMed  Google Scholar 

  39. http://apps.who.int/gho/data/view.main.680.

  40. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167(11):1145–51.

    Article  PubMed  Google Scholar 

  41. Khalangot M, Kravchenko V, Tronko M, Gur’ianov V. Correlation between the prevalence of type 1 diabetes with the daily insulin dose and the autoimmune process against glutamic acid decarboxylase in adults. Eur J Intern Med. 2009;20(6):611–5.

    Article  CAS  PubMed  Google Scholar 

  42. Khalangot M, Tronko M, Okhrimenko N, Kravchenko V, Gurianov V, Tronko M. Prevalence of type 1 diabetes correlates with daily insulin dose, adverse outcomes and with autoimmune process against glutamic acid decarboxylase in adults. Rijeka, Croatia: INTECH Open Access Publisher; 2011.

    Google Scholar 

  43. Khalangot M. Current practice of insulin and oral hypoglycaemic agents treatment of diabetes mellitus type 2 patients according to diabetes mellitus register data analysis in the city of Donetsk, Ukraine. Prim Care Diabetes. 2007;1(4):224.

    Article  Google Scholar 

  44. Khalangot M, Hu G, Tronko M, Kravchenko V, Guryanov V. Gender risk of nonfatal stroke in type 2 diabetic patients differs depending on the type of treatment. J Womens Health (Larchmt). 2009;18(1): 97–103.

    Article  Google Scholar 

  45. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart. 2009;95(6):454–560.

    Article  CAS  PubMed  Google Scholar 

  46. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Diabetes Res Clin Pract. 2008;82(1):139–47.

    Article  CAS  PubMed  Google Scholar 

  47. Khalangot M, Kovtun V. Evaluation approach can significantly influence oral glucose-lowering drugs total mortality risks in retrospective cohorts of type 2 diabetes mellitus patients. Curr Diabetes Rev. 2014;10(5):336–42.

    Article  CAS  PubMed  Google Scholar 

  48. Khalangot ND. Age related and sex peculiarities of mortality from diabetes mellitus type 1 (based on analysis of data of Ukraine’s diabetes mellitus Register) [Article in Ukrainian]. Problemy starenia I dolgoletia. 2008;17(1):75–82. http://www.geront.kiev.ua/psid-2010/2008_1.pdf#page=75.

  49. Khalangot MD, Kravchenko VI, Okhrimenko NV, Kovtun VA, Tronko EM. Analysis of mortality, proliferative retinopathy prevalence, and arterial hypertension among type 1 diabetic patients residing in areas that differ in prevalence of this disease. Endocrinologia. 2009;14(1):77–85. Article in Ukrainian.

    Google Scholar 

  50. Khalangot MD, Tronko MD, Kravchenko VI, Kovtun VA, Okhrimenko NV, Bolgarska SV. Some mortality risk factors for type 1 diabetes mellitus patients in Ukraine evaluated according to data from National Register. Endocrinologia. 2010;15(1):62–70. Article in Ukrainian.

    Google Scholar 

  51. Khalangot MD, Kovtun VA, Okhrimenko NV, Sokolova LK, Bolgarska SV. Approaches to an assessment of probable funds required for treatment of patients with diabetes mellitus in Ukraine УКP. MEД. ЧACOПИC, 3 (89) – V/VI 2012|[Article in Ukrainian]. http://www.umj.com.ua/article/12340/.

  52. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia. 2006;49:660–6.

    Article  CAS  PubMed  Google Scholar 

  53. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes mellitus. Am J Cardiol. 1987;59:750–5.

    Article  CAS  PubMed  Google Scholar 

  54. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM: gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol. 1996;16:720–6.

    Article  CAS  PubMed  Google Scholar 

  55. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000;101:2040–6.

    Article  CAS  PubMed  Google Scholar 

  56. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16(6):466–71.

    Article  CAS  PubMed  Google Scholar 

  57. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH, EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008;31(7):1360–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, Becker DJ, Cavender DE, Drash AL. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984;33(3): 271–6.

    Article  CAS  PubMed  Google Scholar 

  59. Maahs DM, Rewers M, editors. Mortality and renal disease in type 1 diabetes mellitus—progress made, more to be done. J Clin Endocrinol Metab. 2006;91(10):3757–59.

    Google Scholar 

  60. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.

    Article  CAS  PubMed  Google Scholar 

  61. Lumey LH, Stein AD, Susser E. Prenatal famine and adult health. Annu Rev Public Health. 2011;32:237–62.

    Article  CAS  PubMed  Google Scholar 

  62. Lumey LH, Stein AD, Kahn HS. Food restriction during gestation and impaired fasting glucose or glucose tolerance and type 2 diabetes mellitus in adulthood: evidence from the Dutch Hunger Winter Families Study. J Dev Orig Health Dis. 2009;1:S164.

    Google Scholar 

  63. Li Y, He Y, Qi L, et al. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes. 2010;59:2400–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Thurner S, Klimek P, Szell M, et al. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century. Proc Natl Acad Sci U S A. 2013;110:4703–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Lumey LH, Khalangot MD, Vaiserman AM. Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study. Lancet Diabetes Endocrinol. 2015;3:787–94.

    Article  CAS  PubMed  Google Scholar 

  66. Laron Z, Lewy H, Wilderman I, et al. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J. 2005;7:381–4.

    PubMed  Google Scholar 

  67. Vaiserman AM, Carstensen B, Voitenko VP, et al. Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine. Diabetologia. 2007;50:32–5.

    Article  CAS  PubMed  Google Scholar 

  68. Vaiserman AM, Khalangot MD, Carstensen B, et al. Seasonality of birth in adult type 2 diabetic patients in three Ukrainian regions. Diabetologia. 2009;52:2665–7.

    Article  CAS  PubMed  Google Scholar 

  69. Jensen CB, Zimmermann E, Gamborg M, et al. No evidence of seasonality of birth in adult type 2 diabetes in Denmark. Diabetologia. 2015;58:2045–50.

    Article  CAS  PubMed  Google Scholar 

  70. Vaiserman A, Khalangot M. Similar seasonality of birth in type 1 and type 2 diabetes patients: a sign for common etiology? Med Hypotheses. 2008;71: 604–5.

    Article  PubMed  Google Scholar 

  71. Wilkin TJ. Changing perspectives in diabetes: their impact on its classification. Diabetologia. 2007;50:1587–92.

    Article  CAS  PubMed  Google Scholar 

  72. Chistiakov DA, Savost’anov KV, Nosikov VV. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population. BMC Genet. 2001;2(1):6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Chistiakov DA, Zotova EV, Savost’anov KV, Bursa TR, Galeev IV, Strokov IA, Nosikov VV. The 262T> C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metabol. 2006;32(1):63–8.

    Article  CAS  Google Scholar 

  74. Chistiakov DA, Potapov VA, Khodirev DC, Shamkhalova MS, Shestakova MV, Nosikov VV. Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes. Acta Diabetol. 2009;46:43–9.

    Article  CAS  PubMed  Google Scholar 

  75. Sokolova EA, Bondar IA, Shabelnikova OY, Pyankova OV, Filipenko ML. Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) association in Russian Diabetes Mellitus 2 type cohort and meta-analysis. PLoS ONE. 2015;10(5):e0124662.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Globa E, Zelinska N, Mackay DJ, Temple KI, Houghton JA, Hattersley AT, Flanagan SE, Ellard S. Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment. J Pediatr Endocrinol Metab. 2015;28(11–12):1279–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Grulich-Henn J, Wagner V, Thon A, Schober E, Marg W, et al. Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med. 2010;27:709–12.

    Article  CAS  PubMed  Google Scholar 

  78. Iafusco D, Massa O, Pasquino B, Colombo C, Iughetti L, Early Diabetes Study Group of ISPED, et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol. 2012;49:405–8.

    Article  CAS  PubMed  Google Scholar 

  79. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Org; 1999. WHO/NCD/NCS/99.2.

    Google Scholar 

  80. Дeдoв И.И., Шecтaкoвa M.B., Maкcимoвa M.A. Фeдepaльнaя цeлeвaя пpoгpaммa «Caxapный диaбeт» (Meтoдичecкиe peкoмeндaции).- M., 2003.- C.42–46. http://www.voed.ru/fcp_sd.htm.

  81. УHIФIКOBAHИЙ КЛIHIЧHИЙ ПPOTOКOЛ ПEPBИHHOЇ TA BTOPИHHOЇ (CПEЦIAЛIЗOBAHOЇ) MEДИЧHOЇ ДOПOMOГИ ЦУКPOBИЙ ДIAБET 2 TИПУ Approved by Health Ministry of Ukraine, 21.12.2012 №1118. http://www.moz.gov.ua/docfiles/dod1118_2_2012.pdf.

  82. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7.

    Article  Google Scholar 

  83. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement 1):S81–90.

    Article  Google Scholar 

  84. Dreval’ AV, Misnikova IV, Barsukov IA, Ponchakova GV, Kuznetsov AV. Prevalence of type 2 diabetes mellitus and other abnormalities of carbohydrate metabolism depending on diagnostic criteria Caxapный диaбeт, 2010 (1) 116–120. http://cyberleninka.ru/article/n/rasprostranennost-saharnogo-diabeta-2-tipa-i-drugih-narusheniy-uglevodnogo-obmena-v-zavisimosti-ot-kriteriev-diagnostiki.

  85. Vaychulis IA, Shaposhnik II, Vaychulis TN. Peзультaты cкpинингa caxapнoгo диaбeтa2 типa и дpугиx нapушeний углeвoднoгo oбмeнa cpeди paбoтaющeгo нaceлeния Чeлябинcкa. Caxapный диaбeт. 2006;9(4):51–5. http://cyberleninka.ru/article/n/rezultaty-skrininga-saharnogo-diabeta-2-tipa-i-drugih-narusheniy-uglevodnogo-obmena-sredi-rabotayuschego-naseleniya-chelyabinska.

    Google Scholar 

  86. Dogadin SA, Artemenko GP, Tsyplyakova NB, Subrakova NI, Dazidenko LN, Boyko SA, … & Veselkin DA. Peзультaты cкpинингa caxapнoгo диaбeтaу житeлeй г. Aбaкaнa (Pecпубликa Xaкacия). Caxapный диaбeт. 2008;11(2):55–58. http://endojournals.ru/index.php/dia/article/viewFile/5761/3539.

  87. Andel M, Grzeszczak W, Michalek J, Medvescek M, Norkus A, Rasa I, Niewada M, Kamiński B, Kraml P, Madacsy L, DEPAC Group. A multinational, multi centre, observational, cross sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey). Diabetic Medicine. 2008;25(10):1195–203.

    Article  CAS  PubMed  Google Scholar 

  88. Gill GV, Yudkin JS, Keen H, Beran D. The insulin dilemma in resource-limited countries. A way forward? Diabetologia. 2010. doi:10.1007/s00125-010-1897-3.

    Google Scholar 

  89. WHO, World Health Statistics. Annual electronic File, July, 2001 version. Geneve. Retrieved 30 Jan 2004.

    Google Scholar 

  90. Gorter KJ, Wens J, Khunti K, Claramunt XC, Topsever P, Drivsholm T, … Rurik I. The European EUCCLID pilot study on care and complications in an unselected sample of people with type 2 diabetes in primary care. Prim Care Diabetes. 2010;4(1):17–23.

    Google Scholar 

  91. McKnight JA, Wild SH, Lamb MJE, Cooper MN, Jones TW, Davis EA, Hofer S, Fritsch M, Schober E, Svensson J, Almdal T, Young R, Warner JT, Delemer B, Souchon PF, Holl RW, Karges W, Kieninger DM, Tigas S, Bargiota A, Sampanis C, Cherubini V, Gesuita R, Strele I, Pildava S, Coppell KJ, Magee G, Cooper JG, Dinneen SF, Eeg-Olofsson K, Svensson AM, Gudbjornsdottir S, Veeze H, Aanstoot HJ, Khalangot M, Tamborlane WV, Miller KM. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036–50.

    Article  CAS  PubMed  Google Scholar 

  92. Kravchenko VI, Tronko ND, Pankiv VI, Venzilovich YM, Prudius FG. Prevalence of diabetes mellitus and its complications in the Ukraine. Diabetes Res Clin Pract. 1996;34:S73–8.

    Article  PubMed  Google Scholar 

  93. Kühlbrandt C, Basu S, Mckee M, Stuckler D. Looking at the Russian health care system: through the eyes of patients with diabetes and their physicians. Br J Diabetes Vasc Dis. 2012;12(4):181–4.

    Article  Google Scholar 

  94. Richardson E, Roberts B, Sava V, Menon R, McKee M. Health insurance coverage and health care access in Moldova. Health Policy Plan. 2012;27(3):204–12.

    Article  PubMed  Google Scholar 

  95. Shishkin S, Jowett M. A review of health financing reforms in the Republic of Moldova, Health financing policy paper no. 1. Copenhagen: WHO Regional Office for Europe; 2012.

    Google Scholar 

  96. Domente S, Turcanu G, Habicht J, Richardson E. Developments in primary health care in the Republic of Moldova: essential steps to improving access to services. Eurohealth. 2013;19(2):28–31.

    Google Scholar 

  97. Rutkowski B. Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Nephrol Dial Transplant. 2006;21(1):4–10.

    Article  PubMed  Google Scholar 

  98. Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager KJ. Renal replacement therapy in Ukraine: epidemiology and international comparisons. Clin Kidney J. 2014;7(3):330–5.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Buysschaert M, Hermans MP. Non-pharmacological management of type 2 diabetes. Acta Clin Belg. 2004;59(1):14–9.

    Article  CAS  PubMed  Google Scholar 

  100. Diamond J. The double puzzle of diabetes. Nature. 2003;423:599–602.

    Article  CAS  PubMed  Google Scholar 

  101. Kyrylyuk M. Balneotherapy, pelotherapy and physiotherapy of diabetes mellitus. Клiнiчнa eндoкpинoлoгiя тa eндoкpиннa xipуpгiя. 2010;(1):68–76. https://scholar.google.com/scholar?q=+Kyrylyuk+M.+%282010%29+Balneotherapy%2C+pelotherapy+and+physiotherapy+of+diabetes+mellitus.

  102. Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J. 2011;32:1900–8.

    Article  CAS  PubMed  Google Scholar 

  103. Perlman F, Balabanova D. Prescription for change: accessing medication in transitional Russia. Health Policy Plan. 2011;26(6):453–63.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Khalangot M. Current practice of insulin and oral hypoglycaemic agents treatment of diabetes mellitus type 2 patients according to diabetes mellitus register data analysis in the city of Donetsk, Ukraine. Prim Care Diab. 2007;1(4):224.

    Google Scholar 

  105. Yung LM, Yung M, Yao X, Chen ZY, Huang Y, Leung FP. Exercise, vascular wall and cardiovascular diseases. Sports Med. 2009;39(1):45–63.

    Article  PubMed  Google Scholar 

  106. Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, … Roden M. Take action to prevent diabetes – the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metabol Res. 2010;42:S37–55.

    Google Scholar 

  107. Schepelkevich AP, Kholodova EA, Salko OB, et al. Assessment of risk of type 2 diabetes mellitus development in the republic of Belarus (in Russian). Zdravookhranenie. 2012;11:4–8. http://rsml.med.by/diab/p19.pdf.

    Google Scholar 

  108. Færch K, Borch-Johnsen K, Holst JJ, Vaag A. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia. 2009;52(9):1714–23.

    Article  PubMed  Google Scholar 

  109. Engberg S, Glümer C, Witte DR, Jørgensen T, Borch-Johnsen K. Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study. Diabetologia. 2010;53(1):70–8.

    Article  CAS  PubMed  Google Scholar 

  110. Khalangot ND, Kravchenko VI, Okhrimenko NV, Pysarenko YuM, Koliasa OS, Kovtun VA, Gurianov VG, Tronko MD. Anthropometric differences of persons with various types of screen-detected hyperglycemia in rural Ukraine. Zurnal NAMN Ukrainy. 2015;21(3–4):342–50.

    Google Scholar 

  111. Vogel M, Blaak E, Goossens G. Moderate hypoxia exposure: a novel strategy to improve glucose metabolism in humans? EMJ Diabetes. 2015; 3(1):73–9.

    Google Scholar 

  112. Serebrovska TV, Shatilo VB. Remote ischemic preconditioning versus intermittent hypoxia training: a comparative analysis for cardioprotection. Fiziolohichnyi zhurnal. 2014;61(3):99–117.

    Google Scholar 

  113. Korkushko OV, Shatilo VB, Chyzhova VP, Naskalova SS, Osmak YeD, Gremiakov AV, Antoniuk-Scheglova IA, Gavalko GV, Naumchuk NS. Organism reaction to dosed hypoxic hypoxia in the healthy subjects and individuals with prediabetic metabolism disturbances Fiziolohichnyi zhurnal. 2016 (in press).

    Google Scholar 

  114. Shatilo VB, Korkushko OV, Chizhova VP, Naskalova SS, Gavalko AV, Antoniuk-Shcheglova IA, Gremiakov AV, Osmak D, Zhuravleva D, Yu B. Efficacy of using interval normobaric hypoxic exercise training in elderly patients with prediabetic derangements of carbohydrate metabolism. Problemy stareniia I dolgoletia. 2015;24:3–4 (in press).

    Google Scholar 

  115. Suntsov YuI, Bolotskaya LL, Maslova OV, Kazakov IV. Epidemiology of diabetes mellitus and prognosis of its prevalence in the Russian Federation. Caxapный диaбeт, (1). http://cyberleninka.ru/article/n/epidemiologiya-saharnogo-diabeta- i-prognoz-ego-rasprostranennosti-v-rossiyskoy-federatsii.

  116. Tronko M, Khalangot M, Kravcenko V, et al. Gender distribution in Ukrainian adult insulin-treated diabetics depending of age at diagnosis. Endocr Abstr. 2006;11:298. http://www.endocrine-abstracts.org/ea/0011/ea0011P298.htm.

  117. Khalangot MD, Gurianov VG, Vaiserman AM. Gender differences in prevalence of diagnosed type 2 diabetes and patient’s body mass index in five Ukraine regions with diverse historical backgrounds. BIO. 2012;2:1–10.

    Article  Google Scholar 

  118. Gale EA, Gillespie KM. Diabetes and gender. Diabetologia. 2001;44:3–15.

    Article  CAS  PubMed  Google Scholar 

  119. Perlman F, McKee M. Diabetes during the Russian transition. Diabetes Res Clin Pract. 2008;80(2):305–13.

    Article  PubMed  Google Scholar 

  120. Thurner S, Klimek P, Szell M, Duftschmid G, Endel G, Kautzky-Willer A, Kasper DC. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century. Proc Natl Acad Sci. 2013;110(12):4703–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. van Abeelen AF, Elias SG, Bossuyt PM, Grobbee DE, van der Schouw YT, Roseboom TJ, Uiterwaal CS. Famine exposure in the young and the risk of type 2 diabetes in adulthood. Diabetes. 2012;61(9):2255–60.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Polyakova IV, Glotov OS, Khoroshinina LP, Turjeva LV, Ivashchenko TE, Baranov VS. Genotype and allele frequencies of UCP and PPAR gene families in residents of besieged Leningrad and in the control group. Adv Gerontol. 2014;27(3):418–24.

    Google Scholar 

  123. Mankovsky BN, Metzger BE, Molitch ME, Biller J. Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complicat. 1996;10(4):228–42.

    Article  CAS  PubMed  Google Scholar 

  124. Popova V, Zak K, Gruzov M, Afanasyeva V, Simeonova T, Mankovsky B. The prognostic value of the immunological phenotype of lymphocytes in subjects positive for diabetes-associated autoantibodies. Diabetologia. 2006;49:280–1. 233.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mykolay Khalangot MD, ScD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Khalangot, M., Gurianov, V., Vaiserman, A., Strele, I., Fedash, V., Kravchenko, V. (2017). Diabetes in Eastern Europe. In: Dagogo-Jack, S. (eds) Diabetes Mellitus in Developing Countries and Underserved Communities. Springer, Cham. https://doi.org/10.1007/978-3-319-41559-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-41559-8_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41557-4

  • Online ISBN: 978-3-319-41559-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics